The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 04, 2025
Filed:
Jan. 19, 2024
Applicant:
Risen (Suzhou) Pharma Tech Co., Ltd., Jiangsu, CN;
Inventors:
Jiasheng Lu, Shanghai, CN;
Jiamin Gu, Suzhou, CN;
Xinyong Lv, Suzhou, CN;
Guowei Song, Suzhou, CN;
Dongdong Wu, Suzhou, CN;
Daiqiang Hu, Suzhou, CN;
Jun Gu, Suzhou, CN;
Gang Chen, Suzhou, CN;
Xiang Ji, Suzhou, CN;
Xiuchun Zhang, Suzhou, CN;
Jinchao Ai, Suzhou, CN;
Xianqi Kong, Dollard-des-Ormeaux, CA;
Assignee:
RISEN (SUZHOU) PHARMA TECH CO., LTD., Suzhou, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 309/14 (2006.01); C07B 59/00 (2006.01); C07C 309/15 (2006.01); C07C 309/59 (2006.01); C07D 233/61 (2006.01);
U.S. Cl.
CPC ...
C07C 309/14 (2013.01); C07B 59/001 (2013.01); C07B 59/002 (2013.01); C07C 309/15 (2013.01); C07C 309/59 (2013.01); C07D 233/61 (2013.01); C07B 2200/05 (2013.01);
Abstract
There are provided isotope-enriched compounds of Formula (I) and pharmaceutically acceptable salts or esters thereof, as well as pharmaceutical compositions thereof and methods of use thereof for prevention and treatment of amyloid-β related diseases, such as Alzheimer's disease.RRX—CR—CH—CH—SOH (I)